Patient Guide: Study to Evaluate the Efficacy and Safety of Atezolizumab and Bevacizumab as Neoadjuvant Plus Adjuvant Treatment in HCC

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • Get matched to the right study location for you
  • Connect directly with study coordinators at 13 participating sites
  • Understand eligibility with our simplified screening tool
  • Free service - we're here to help you access clinical research
Trial ID: NCTNCT07018947
Status: NOT_YET_RECRUITING
Condition: Resectable Hepatocellular Carcinoma
Phase: PHASE2

Find a Study Location Near You

This study is available at 13 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • Santiago De Compostela, A Coruña
  • Badalona, Barcelona
  • Santander, Cantabria
  • • And 10 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily